Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease

作者: Ilaria Croci , Nuala M Byrne , Stéphane Choquette , Andrew P Hills , Veronique S Chachay

DOI: 10.1136/GUTJNL-2012-302789

关键词:

摘要: Objectives In non-alcoholic fatty liver disease (NAFLD), hepatic steatosis is intricately linked with a number of metabolic alterations. We studied substrate utilisation in NAFLD during basal, insulin-stimulated and exercise conditions, correlated these outcomes severity. Methods 20 patients (mean±SD body mass index (BMI) 34.1±6.7 kg/m 2 ) 15 healthy controls (BMI 23.4±2.7 kg/m were assessed. Respiratory quotient (RQ), whole-body fat (Fat ox carbohydrate (CHO oxidation rates determined by indirect calorimetry three conditions: basal (resting fasted), (hyperinsulinaemic–euglycaemic clamp) (cycling at an intensity to elicit maximal Fat ). Severity histology, from plasma β-hydroxybutyrate concentrations, aerobic fitness expressed as , visceral adipose tissue (VAT) measured computed tomography. Results Within the overweight/obese cohort, RQ positively (r=0.57, p=0.01) was higher (indicating smaller contribution energy expenditure) activity score (NAS) ≥5 vs (1.2±0.3 1.5±0.4 mg/kgFFM/min, p=0.024) lower (ie, β-hydroxybutyrate, p=0.004). During exercise, they achieved (2.5±1.4 vs. 5.8±3.7 p=0.002) (p not associated severity (p=0.79). Conclusions Overweight/obese had reduced under conditions. There inverse relationship between ability oxidise conditions histological features including NAS.

参考文章(57)
Elizabeth M Brunt, David E Kleiner, Laura A Wilson, Patricia Belt, Brent A Neuschwander‐Tetri, NASH Clinical Research Network (CRN), None, Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings Hepatology. ,vol. 53, pp. 810- 820 ,(2011) , 10.1002/HEP.24127
AS Jackson, PR Stanforth, J Gagnon, T Rankinen, AS Leon, DC Rao, JS Skinner, C Bouchard, JH Wilmore, The effect of sex, age and race on estimating percentage body fat from body mass index: The Heritage Family Study. International Journal of Obesity. ,vol. 26, pp. 789- 796 ,(2002) , 10.1038/SJ.IJO.0802006
James E. Hansen, Exercise Instruments, Schemes, and Protocols for Evaluating the Dyspneic Patient1–3 The American review of respiratory disease. ,vol. 129, ,(2015) , 10.1164/ARRD.1984.129.2P2.S25
Elisa Fabbrini, B. Selma Mohammed, Faidon Magkos, Kevin M. Korenblat, Bruce W. Patterson, Samuel Klein, Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease Gastroenterology. ,vol. 134, pp. 424- 431 ,(2008) , 10.1053/J.GASTRO.2007.11.038
Lauren N Bell, Jiangxia Wang, Sriya Muralidharan, Sadhana Chalasani, Allison M Fullenkamp, Laura A Wilson, Arun J Sanyal, Kris V Kowdley, Brent A Neuschwander‐Tetri, Elizabeth M Brunt, Arthur J McCullough, Nathan M Bass, Anna Mae Diehl, Aynur Unalp‐Arida, Naga Chalasani, Nonalcoholic Steatohepatitis Clinical Research Network, None, Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. Hepatology. ,vol. 56, pp. 1311- 1318 ,(2012) , 10.1002/HEP.25805
Elizabeth M. Brunt, Nonalcoholic steatohepatitis: definition and pathology. Seminars in Liver Disease. ,vol. 21, pp. 3- 16 ,(2001) , 10.1055/S-2001-12925
E. Bugianesi, A. Gastaldelli, E. Vanni, R. Gambino, M. Cassader, S. Baldi, V. Ponti, G. Pagano, E. Ferrannini, M. Rizzetto, Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms Diabetologia. ,vol. 48, pp. 634- 642 ,(2005) , 10.1007/S00125-005-1682-X
Anna Kotronen, Anneli Seppälä-Lindroos, Satu Vehkavaara, Robert Bergholm, Keith N. Frayn, Barbara A. Fielding, Hannele Yki-Järvinen, Liver fat and lipid oxidation in humans. Liver International. ,vol. 29, pp. 1439- 1446 ,(2009) , 10.1111/J.1478-3231.2009.02076.X
Luca Valenti, Ahmad Al-Serri, Ann K. Daly, Enrico Galmozzi, Raffaela Rametta, Paola Dongiovanni, Valerio Nobili, Enrico Mozzi, Giancarlo Roviaro, Ester Vanni, Elisabetta Bugianesi, Marco Maggioni, Anna Ludovica Fracanzani, Silvia Fargion, Christopher P. Day, Homozygosity for the patatin-like phospholipase-3/adiponutrin i148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease Hepatology. ,vol. 51, pp. 1209- 1217 ,(2010) , 10.1002/HEP.23622
Juul Achten, Asker E Jeukendrup, Optimizing fat oxidation through exercise and diet Nutrition. ,vol. 20, pp. 716- 727 ,(2004) , 10.1016/J.NUT.2004.04.005